Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 2.47
- Piotroski Score 6.00
- Grade Hold
- Symbol (AMN)
- Company AMN Healthcare Services, Inc.
- Price $25.84
- Changes Percentage (0.54%)
- Change $0.14
- Day Low $25.63
- Day High $26.36
- Year High $80.22
AMN Healthcare Services, Inc. provides healthcare workforce solutions and staffing services to hospitals and healthcare facilities in the United States. It operates through three segments: Nurse and Allied Solutions, Physician and Leadership Solutions, and Technology and Workforce Solutions. The Nurse and Allied Solutions segment offers travel nurse staffing, rapid response nurse staffing and labor disruption, allied staffing, local staffing, and revenue cycle solutions. The Physician and Leadership Solutions segment provides locum tenens staffing, healthcare interim leadership staffing, executive search, and physician permanent placement solutions. The Technology and Workforce Solutions segment offers language services, vendor management systems, workforce optimization, telehealth, credentialing, and outsourced solutions. The company also provides allied health professionals, such as physical therapists, respiratory therapists, occupational therapists, medical and radiology technologists, lab technicians, speech pathologists, rehabilitation assistants, and pharmacists. It offers its services under the brands, including American Mobile, Nursefinders, NurseChoice, HealthSource Global Staffing, Onward Healthcare, O'Grady Peyton International, Med Travelers, Club Staffing, Staff Care, B.E. Smith, and Merritt Hawkins, as well as AMN Revenue Cycle Solutions and AMN Language Services. The company was founded in 1985 and is based in Dallas, Texas.
- Last Earnings 09/27/2011
- Ex-Dividend for 5/16 Dividend 09/29/2011
- Dividend Payable N/A
- Today N/A
- Next Earnings (Estimated) 02/13/2025
- Fiscal Year End N/A
- Average Stock Price Target $57.00
- High Stock Price Target $175.00
- Low Stock Price Target $46.00
- Potential Upside/Downside N/A
- Consensus Rating Neutral
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $3.79
- Trailing P/E Ratio 14.3
- Forward P/E Ratio 14.3
- P/E Growth 14.3
- Net Income $210.68 M
Income Statement
Quarterly
Annual
Latest News of AMN
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Amneal Resubmits New Drug Application for Migraine Treatment, Diabetes Drug Is Approved
Amneal Pharmaceuticals resubmitted a migraine treatment application and received approval for a diabetes and obesity treatment from the FDA. The company's new ready-to-use migraine treatment and GLP-1...
By MarketWatch | 1 day ago -
The most damning crime of Daniel Jones saga as Giants went from hope...
After a standout debut, Daniel Jones brought hope to the Giants, reminiscent of Obama's iconic campaign. Fans were captivated by the rejuvenation he brought, despite doubts on his draft pick. GM Gettl...
By New York Post | 4 days ago -
Book Review: Reader would be 'Damn Glad' to pick up a copy of actor Tim Matheson's new memoir
Tim Matheson, a seasoned actor, writer, and director, shares his fascinating journey in Hollywood in the memoir "Damn Glad to Meet You: My Seven Decades in the Hollywood Trenches....
By AP NEWS | 1 week ago
